| NCT ID | NCT04864080 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Minnesota |
| Condition | Pain |
| Study Type | INTERVENTIONAL |
| Enrollment | 45 participants |
| Start Date | 2022-04-11 |
| Primary Completion | 2027-03-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 45 participants in total. It began in 2022-04-11 with a primary completion date of 2027-03-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The overall objective of this study is to determine the feasibility of identifying transdiagnostic biomarkers of cognitive function mediated by neuromodulation of the dorsolateral prefrontal cortex that are translatable across disease groups in order to more accurately phenotype clusters of cognitive dysfunction. Completing behavioral paradigms with electrophysiology and TMS is a challenging frontier. This study focuses on the feasibility of such an endeavor for those with chronic pain or depression as well as healthy controls.
Eligibility Criteria
Arm 1, healthy controls: Inclusion Criteria: * Have access to the online study platform. Exclusion Criteria: * under 18, non-English speaking Arm 2: pain and depression: Inclusion Criteria: * Pain or depression Exclusion Criteria: * pregnant women
Contact & Investigator
Frequently Asked Questions
Who can join the NCT04864080 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Pain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04864080 currently recruiting?
Yes, NCT04864080 is actively recruiting participants. Contact the research team at hdlab@umn.edu for enrollment information.
Where is the NCT04864080 trial being conducted?
This trial is being conducted at Minneapolis, United States.
Who is sponsoring the NCT04864080 clinical trial?
NCT04864080 is sponsored by University of Minnesota. The trial plans to enroll 45 participants.